Pharsight

Airduo Digihaler patents expiration

AIRDUO DIGIHALER's oppositions filed in EPO
AIRDUO DIGIHALER Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6718972 TEVA PHARM Dose metering system for medicament inhaler
Jun, 2021

(2 years ago)

US6701917 TEVA PHARM Dose counter for medicament inhaler
Jun, 2021

(2 years ago)

US6748947 TEVA PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US6871646 TEVA PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US8006690 TEVA PHARM Reservoir pressure system for medicament inhaler
Jun, 2021

(2 years ago)

US7540282 TEVA PHARM Reservoir pressure system for medicament inhaler
May, 2023

(11 months ago)

US7540282

(Pediatric)

TEVA PHARM Reservoir pressure system for medicament inhaler
Nov, 2023

(5 months ago)

US9987229 TEVA PHARM Process for preparing a medicament
Sep, 2024

(4 months from now)

US9616024 TEVA PHARM Process for preparing a medicament
Sep, 2024

(4 months from now)

US9616024

(Pediatric)

TEVA PHARM Process for preparing a medicament
Mar, 2025

(10 months from now)

US9987229

(Pediatric)

TEVA PHARM Process for preparing a medicament
Mar, 2025

(10 months from now)

US10765820 TEVA PHARM Dry powder inhalation apparatus
May, 2025

(1 year, 28 days from now)

US9463288 TEVA PHARM Dry powder inhalation apparatus
May, 2025

(1 year, 28 days from now)

US10765820

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Nov, 2025

(1 year, 6 months from now)

US9463288

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Nov, 2025

(1 year, 6 months from now)

US8651103 TEVA PHARM Dry powder inhalation apparatus
Mar, 2028

(3 years from now)

US8651103

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Sep, 2028

(4 years from now)

US10195375 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Feb, 2031

(6 years from now)

US10022510 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(7 years from now)

US9731087 TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(7 years from now)

US10124131 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(7 years from now)

US9216260 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jun, 2031

(7 years from now)

US10195375

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Aug, 2031

(7 years from now)

US9731087

(Pediatric)

TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement
Nov, 2031

(7 years from now)

US10124131

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Nov, 2031

(7 years from now)

US10022510

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Nov, 2031

(7 years from now)

US9216260

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Dec, 2031

(7 years from now)

US10561808 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

US8978966 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jan, 2032

(7 years from now)

US8714149 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Feb, 2032

(7 years from now)

US10561808

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jul, 2032

(8 years from now)

US8978966

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jul, 2032

(8 years from now)

US8714149

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Aug, 2032

(8 years from now)

US9066957 TEVA PHARM Dry powder inhaler
Oct, 2034

(10 years from now)

US9415008 TEVA PHARM Dry powder inhaler
Oct, 2034

(10 years from now)

US9066957

(Pediatric)

TEVA PHARM Dry powder inhaler
Apr, 2035

(10 years from now)

US9415008

(Pediatric)

TEVA PHARM Dry powder inhaler
Apr, 2035

(10 years from now)

US9782550 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

US9782551 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

US10918816 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Dec, 2035

(11 years from now)

US9782550

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Feb, 2036

(11 years from now)

US9782551

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Feb, 2036

(11 years from now)

US10918816

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Jun, 2036

(12 years from now)

US10569034 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2036

(12 years from now)

US10569034

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Feb, 2037

(12 years from now)

US11351317 TEVA PHARM Drug delivery device with electronics
Feb, 2038

(13 years from now)

US11351317

(Pediatric)

TEVA PHARM Drug delivery device with electronics
Aug, 2038

(14 years from now)

US11357935 TEVA PHARM Drug delivery device with electronics
Sep, 2038

(14 years from now)

US11000653 TEVA PHARM Inhaler
Dec, 2038

(14 years from now)

US11000653

(Pediatric)

TEVA PHARM Inhaler
Jun, 2039

(15 years from now)

US11344685 TEVA PHARM Drug delivery device with electronics
Sep, 2039

(15 years from now)

US11344685

(Pediatric)

TEVA PHARM Drug delivery device with electronics
Mar, 2040

(15 years from now)

US11439777 TEVA PHARM Drug delivery device with electronics
May, 2040

(16 years from now)

US11464923 TEVA PHARM Inhaler system
Jun, 2040

(16 years from now)

US11173259 TEVA PHARM Drug delivery device with electronics and power management
Jul, 2040

(16 years from now)

US11173259

(Pediatric)

TEVA PHARM Drug delivery device with electronics and power management
Jan, 2041

(16 years from now)

US11266796 TEVA PHARM Inhalation device with integrated electronics
Feb, 2041

(16 years from now)

US11266796

(Pediatric)

TEVA PHARM Inhalation device with integrated electronics
Aug, 2041

(17 years from now)

Airduo Digihaler is owned by Teva Pharm.

Airduo Digihaler contains Fluticasone Propionate; Salmeterol Xinafoate.

Airduo Digihaler has a total of 58 drug patents out of which 7 drug patents have expired.

Expired drug patents of Airduo Digihaler are:

  • US6718972
  • US6701917
  • US6748947
  • US6871646
  • US8006690
  • US7540282
  • US7540282*PED

Airduo Digihaler was authorised for market use on 12 July, 2019.

Airduo Digihaler is available in powder;inhalation dosage forms.

Airduo Digihaler can be used as treatment of asthma.

The generics of Airduo Digihaler are possible to be released after 22 August, 2041.

Drug Exclusivity Drug Exclusivity Expiration
M(M-61) Jul 09, 2024
Pediatric Exclusivity(PED) Jan 09, 2025
New Product(NP) Jan 27, 2020

Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient

Market Authorisation Date: 12 July, 2019

Treatment: Treatment of asthma

Dosage: POWDER;INHALATION

More Information on Dosage

AIRDUO DIGIHALER family patents

Family Patents